Estimates Revisions CapsoVision, Inc.
Stocks
CV
US1409351079
Advanced Medical Equipment & Technology
|
Market Closed -
Nasdaq
00:00:00 09/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 6.360 USD | +6.18% |
|
+8.35% | -40.51% |
| 08-28 | Outlook Therapeutics Appoints Kevin Lundquist as CFO | MT |
| 08-14 | CapsoVision, Inc., Q2 2026 Earnings Call, Aug 13, 2026 |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- CV Stock
- Consensus CapsoVision, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
